Lacticaseibacillus rhamnosus LR06
Lacticaseibacillus rhamnosus LR06 appears primarily as a component of multi-strain probiotic formulations, where it has been studied alongside other bacterial species in randomized controlled trials. Human RCTs involving these combination products have examined sleep quality, mood, cognitive reactivity, and glucose homeostasis, though isolating the specific contribution of LR06 from co-administered strains is not possible from the available evidence. Earlier work examined intestinal colonization kinetics of encapsulated versus uncoated multi-strain products. In vitro studies have examined its activity against certain Escherichia coli strains. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 12 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 11 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
15 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.